Log on / register
Feedback | Support | My details
Open AccessHighly AccessResearch article

Erythropoietin enhances hippocampal long-term potentiation and memory

Bartosz Adamcio* 1 email, Derya Sargin* 1 email, Alicja Stradomska* 2,3 email, Lucian Medrihan2,3 email, Christoph Gertler4 email, Fabian Theis5 email, Mingyue Zhang2,3 email, Michael Müller2,3 email, Imam Hassouna1 email, Kathrin Hannke1 email, Swetlana Sperling1 email, Konstantin Radyushkin1,3 email, Ahmed El-Kordi1 email, Lizzy Schulze2,3 email, Anja Ronnenberg1 email, Fred Wolf5 email, Nils Brose3,4 email, Jeong-Seop Rhee4 email, Weiqi Zhang2,3 email and Hannelore Ehrenreich1,3 email

1Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Göttingen, Germany

2Dept. of Neurophysiology, Georg-August-University, Göttingen, Germany

3DFG Research Center for Molecular Physiology of the Brain (CMPB), Göttingen, Germany

4Dept. of Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Göttingen, Germany

5Dept. of Nonlinear Dynamics, Max Planck Institute of Dynamics and Self-Organization, Göttingen, Germany

author email corresponding author email* Contributed equally

BMC Biology 2008, 6:37doi:10.1186/1741-7007-6-37

Published: 9 September 2008

Abstract

Background

Erythropoietin (EPO) improves cognition of human subjects in the clinical setting by as yet unknown mechanisms. We developed a mouse model of robust cognitive improvement by EPO to obtain the first clues of how EPO influences cognition, and how it may act on hippocampal neurons to modulate plasticity.

Results

We show here that a 3-week treatment of young mice with EPO enhances long-term potentiation (LTP), a cellular correlate of learning processes in the CA1 region of the hippocampus. This treatment concomitantly alters short-term synaptic plasticity and synaptic transmission, shifting the balance of excitatory and inhibitory activity. These effects are accompanied by an improvement of hippocampus dependent memory, persisting for 3 weeks after termination of EPO injections, and are independent of changes in hematocrit. Networks of EPO-treated primary hippocampal neurons develop lower overall spiking activity but enhanced bursting in discrete neuronal assemblies. At the level of developing single neurons, EPO treatment reduces the typical increase in excitatory synaptic transmission without changing the number of synaptic boutons, consistent with prolonged functional silencing of synapses.

Conclusion

We conclude that EPO improves hippocampus dependent memory by modulating plasticity, synaptic connectivity and activity of memory-related neuronal networks. These mechanisms of action of EPO have to be further exploited for treating neuropsychiatric diseases.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.